A Prospective Research on Diagnosis, Prognosis, and Mechanisms of Panvascular Disease

Status: Recruiting
Location: See location...
Intervention Type: Other
Study Type: Observational
SUMMARY

This study aims to establish a standardized cohort for panvascular diseases, encompassing biological materials such as DNA samples, along with extensive patient medical records and follow-up information. The design of this database will enable it to serve as a comprehensive resource for future medical research. Upon data collection, researchers will conduct various statistical analyses to enhance our understanding of the factors and mechanisms contributing to various panvascular diseases, including coronary heart disease, myocardial infarction, stroke, and peripheral vascular disease. These statistical analyses will also aid in identifying more effective treatment strategies for these conditions. By amassing a large volume of data from a significant number of patients with panvascular diseases, researchers will be able to perform highly precise analyses of the factors influencing the onset, progression, and treatment of these diseases. The results of these precise analyses can then be utilized to optimize clinical practices for the prevention and treatment of panvascular diseases.

Eligibility
Participation Requirements
Sex: All
Minimum Age: 18
Maximum Age: 80
Healthy Volunteers: t
View:

• Male or female aged 18 to 80 years old;

• Diagnosed or suspected panvascular disease, defined as the presence of atherosclerotic lesions in at least two or more vascular regions, such as intracranial arteries, carotid arteries, coronary arteries, aorta, and peripheral arteries;

• Voluntary participation in this study and provision of signed informed consent.

Locations
Other Locations
China
Harbin Medical University
RECRUITING
Harbin
Contact Information
Primary
Tian J Jinwei Tian, MD, PhD
tianjinweidr2009@163.com
+86-0451-86605180
Backup
Wang Y Yan Wang, MD, PhD
wangyandr2022@hrbmu.edu.cn
+86-13936462066
Time Frame
Start Date: 2024-12-01
Estimated Completion Date: 2030-12-31
Participants
Target number of participants: 1000
Sponsors
Leads: Jinwei Tian

This content was sourced from clinicaltrials.gov